Clinical trial
Nexium RESPONSE Trial
NCT00318968 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00318968 |
|---|---|
| Title | Nexium RESPONSE Trial |
| Official title | Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | Esomeprazole |
| Enrollment | 1,000 |
| Start date | May 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | Apr 27, 2006 |
| Last update posted | Jan 26, 2009 |
| Countries | Denmark |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: